Jubilant Pharmova Limited — Board Meeting, 10-08-2026: Outcome of Board Meeting
10-08-2026 | 07:16 pm
10-08-2026 | 07:16 pm
Jubilant Pharmova's Board met and approved Q1 FY27 consolidated financial results. Total revenue for the quarter stood at ₹2,229.4 Cr, with a profit for the period of ₹56.4 Cr.
No comments yet. Be the first to comment!
